Prediction and prevention of type 1 diabetes;Prädiktion und prävention des Typ-1-diabetes

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 20, 2001, Pages 593-596

  Schmid, S ^a   Ziegler, A G ^a  

^a Klinikum Schwabing   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; PHOSPHATASE;

ANTIBODY SCREENING; CLINICAL TRIAL; DISEASE MARKER; GENETIC MARKER; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MASS SCREENING; METABOLISM; PREDICTION; PRIMARY PREVENTION; SECONDARY PREVENTION; SERODIAGNOSIS; SHORT SURVEY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; ISLETS OF LANGERHANS;

EID: 0035906872     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14096     Document Type: Short Survey

References (24)

1. Modulation of the appearance of diabetes associated autoantibodies in the nutritional prevention of type 1 diabetes (TRIGR) project
2. The pathogenisis of insulin-dependent diabetes mellitus
3. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers
4. Proposed guidelines on screening for risk of type 1 diabetes
5. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins
6. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives
7. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM
8. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: A prospective multicenter study
9. Delay of type 1 diabetes in high risk, first degree relatives by parenteral antigen administration: The Schwabing Insulin Prophylaxis Pilot Trial
10. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide
11. Distinct genetic and immunological features in patients with onset of IDDM before and after age 40
12. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3
13. Newborn screening for HLA markers associated with IDDM: Diabetes autoimmunity study in the young (DAISY)
14. Combined antibody screening for improved prediction of IDDM - Modern strategies
15. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives
16. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type 1 diabetes: The German BABYDIAB study
17. Immune markers for monitoring the progression of autoimmune disease
18. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function
19. Type I diabetes risk study of a general population: Frequencies and interactions of the four major Type I diabetes-associated autoantibodies studied in 9419 schoolchildren
20. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus
21. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes
22. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
23. Ernst-Friedrich-Pfeiffer Memorial Lecture. New aspects of C-peptide physiology
24. Autoantibody appearance and risk for the development of childhood diabetes in offspring of parents with type I diabetes: The German BABY-DIAB Study